# Eli Lilly and Company timeline

entity: /record/eli-lilly.md  
id: ent_eli-lilly  

Eli Lilly and Company's timeline holds 509 claims from 1994 to 2026: 499 money & deals, 10 other. 7 are undated. The latest took effect on October 26, 2026.

Kinds: People 0 (/timelines/eli-lilly.md?kind=people) · Money & deals 499 (/timelines/eli-lilly.md?kind=money) · Products 0 (/timelines/eli-lilly.md?kind=products) · Models 0 (/timelines/eli-lilly.md?kind=models) · Other 10 (/timelines/eli-lilly.md?kind=other)  
Format: date | kind | predicate | value | status | claim.

## 1994

- 1994-07-27 to 1994-10-14 | other | registrant_name | LILLY ELI & CO ET AL | superseded | [clm_48D2AB64E8F2](/claim/clm_48D2AB64E8F2.md)
- 1994-10-26 to 2019-10-25 | other | registrant_name | LILLY ELI & CO | superseded | [clm_C9CDC9028127](/claim/clm_C9CDC9028127.md)

## 2006

- 2006-12-31 to 2007-12-31 | money | cash_and_equivalents | 3,109,300,000 United States dollar | superseded | [clm_AD699CB69989](/claim/clm_AD699CB69989.md)

## 2007

- 2007-12-31 to 2008-06-30 | money | cash_and_equivalents | 3,220,500,000 United States dollar | superseded | [clm_0D3E370EA1BC](/claim/clm_0D3E370EA1BC.md)
- 2007-12-31 to 2008-12-31 | money | net_income | 2,953,000,000 United States dollar | superseded | [clm_F48D85F877C4](/claim/clm_F48D85F877C4.md)
- 2007-12-31 to 2008-12-31 | money | research_and_development | 3,486,700,000 United States dollar | superseded | [clm_A38CF4ED791C](/claim/clm_A38CF4ED791C.md)
- 2007-12-31 to 2008-12-31 | money | revenue | 18,633,500,000 United States dollar | superseded | [clm_6C192C099D33](/claim/clm_6C192C099D33.md)

## 2008

- 2008-06-30 to 2008-09-30 | money | cash_and_equivalents | 2,868,300,000 United States dollar | superseded | [clm_BCE9C7519379](/claim/clm_BCE9C7519379.md)
- 2008-06-30 to 2008-09-30 | money | quarterly_net_income | 958,800,000 United States dollar | superseded | [clm_23B6FA8228EF](/claim/clm_23B6FA8228EF.md)
- 2008-06-30 to 2008-09-30 | money | quarterly_research_and_development | 951,500,000 United States dollar | superseded | [clm_DBACEC763B3F](/claim/clm_DBACEC763B3F.md)
- 2008-06-30 to 2008-09-30 | money | quarterly_revenue | 5,150,400,000 United States dollar | superseded | [clm_1102EFDDC838](/claim/clm_1102EFDDC838.md)
- 2008-09-30 to 2008-12-31 | money | cash_and_equivalents | 4,353,600,000 United States dollar | superseded | [clm_1D6956B778D3](/claim/clm_1D6956B778D3.md)
- 2008-09-30 to 2009-03-31 | money | quarterly_net_income | -465,600,000 United States dollar | superseded | [clm_2C0E273C772B](/claim/clm_2C0E273C772B.md)
- 2008-09-30 to 2009-03-31 | money | quarterly_research_and_development | 953,000,000 United States dollar | superseded | [clm_5846C31AE43C](/claim/clm_5846C31AE43C.md)
- 2008-09-30 to 2009-03-31 | money | quarterly_revenue | 5,209,500,000 United States dollar | superseded | [clm_FC4E2F880E31](/claim/clm_FC4E2F880E31.md)
- 2008-12-31 to 2009-03-31 | money | cash_and_equivalents | 5,496,700,000 United States dollar | superseded | [clm_483FA20E20C6](/claim/clm_483FA20E20C6.md)
- 2008-12-31 to 2009-12-31 | money | net_income | -2,071,900,000 United States dollar | superseded | [clm_A9151DC389AD](/claim/clm_A9151DC389AD.md)
- 2008-12-31 to 2009-12-31 | money | research_and_development | 3,840,900,000 United States dollar | superseded | [clm_AFD07F967D55](/claim/clm_AFD07F967D55.md)
- 2008-12-31 to 2009-12-31 | money | revenue | 20,371,900,000 United States dollar | superseded | [clm_F31DE382AAED](/claim/clm_F31DE382AAED.md)
- 2008-12-31 to 2009-06-30 | money | total_assets | 29,212,600,000 United States dollar | superseded | [clm_9CDC07565E1C](/claim/clm_9CDC07565E1C.md)
- 2008-12-31 to 2009-06-30 | money | total_equity | 6,737,700,000 United States dollar | superseded | [clm_EF820B53A635](/claim/clm_EF820B53A635.md)

## 2009

- 2009-03-31 to 2009-06-30 | money | cash_and_equivalents | 3,313,100,000 United States dollar | superseded | [clm_B84BC0F12DF0](/claim/clm_B84BC0F12DF0.md)
- 2009-03-31 to 2009-06-30 | money | quarterly_net_income | 1,313,100,000 United States dollar | superseded | [clm_11A5247EA3F6](/claim/clm_11A5247EA3F6.md)
- 2009-03-31 to 2009-06-30 | money | quarterly_research_and_development | 947,300,000 United States dollar | superseded | [clm_F12D855DD720](/claim/clm_F12D855DD720.md)
- 2009-03-31 to 2009-06-30 | money | quarterly_revenue | 5,047,000,000 United States dollar | superseded | [clm_59E4AE9C36CB](/claim/clm_59E4AE9C36CB.md)
- 2009-06-30 to 2009-09-30 | money | cash_and_equivalents | 3,322,300,000 United States dollar | superseded | [clm_E382BCF8A181](/claim/clm_E382BCF8A181.md)
- 2009-06-30 to 2009-09-30 | money | quarterly_net_income | 1,158,500,000 United States dollar | superseded | [clm_F59E65369CFD](/claim/clm_F59E65369CFD.md)
- 2009-06-30 to 2009-09-30 | money | quarterly_research_and_development | 1,040,400,000 United States dollar | superseded | [clm_10AEF85D5BA1](/claim/clm_10AEF85D5BA1.md)
- 2009-06-30 to 2009-09-30 | money | quarterly_revenue | 5,292,800,000 United States dollar | superseded | [clm_7DCE73A04E98](/claim/clm_7DCE73A04E98.md)
- 2009-06-30 to 2009-09-30 | money | total_assets | 26,931,500,000 United States dollar | superseded | [clm_70F0A12AA6B3](/claim/clm_70F0A12AA6B3.md)
- 2009-06-30 to 2009-09-30 | money | total_equity | 8,560,000,000 United States dollar | superseded | [clm_C10711390F1D](/claim/clm_C10711390F1D.md)
- 2009-07-20 to 2009-10-20 | money | shares_outstanding | 1,149,021,510 shares | superseded | [clm_78D371C35EC1](/claim/clm_78D371C35EC1.md)
- 2009-09-30 to 2009-12-31 | money | cash_and_equivalents | 3,848,200,000 United States dollar | superseded | [clm_190352900D17](/claim/clm_190352900D17.md)
- 2009-09-30 to 2010-03-31 | money | quarterly_net_income | 941,800,000 United States dollar | superseded | [clm_36724E08FB42](/claim/clm_36724E08FB42.md)
- 2009-09-30 to 2010-03-31 | money | quarterly_research_and_development | 1,122,100,000 United States dollar | superseded | [clm_15E0E04D9E8A](/claim/clm_15E0E04D9E8A.md)
- 2009-09-30 to 2010-03-31 | money | quarterly_revenue | 5,562,000,000 United States dollar | superseded | [clm_DC9E250C63CB](/claim/clm_DC9E250C63CB.md)
- 2009-09-30 to 2009-12-31 | money | total_assets | 27,127,900,000 United States dollar | superseded | [clm_5A19DBD93FC2](/claim/clm_5A19DBD93FC2.md)
- 2009-09-30 to 2009-12-31 | money | total_equity | 9,905,000,000 United States dollar | superseded | [clm_76B236DB1A35](/claim/clm_76B236DB1A35.md)
- 2009-10-20 to 2010-02-12 | money | shares_outstanding | 1,149,022,405 shares | superseded | [clm_2ED8FC221F63](/claim/clm_2ED8FC221F63.md)
- 2009-12-31 to 2010-03-31 | money | cash_and_equivalents | 4,462,900,000 United States dollar | superseded | [clm_D62236685DDC](/claim/clm_D62236685DDC.md)
- 2009-12-31 to 2010-12-31 | money | net_income | 4,328,800,000 United States dollar | superseded | [clm_5EE235488841](/claim/clm_5EE235488841.md)
- 2009-12-31 to 2010-12-31 | money | research_and_development | 4,326,500,000 United States dollar | superseded | [clm_21AC62604A75](/claim/clm_21AC62604A75.md)
- 2009-12-31 to 2010-12-31 | money | revenue | 21,836,000,000 United States dollar | superseded | [clm_75C93A8D0879](/claim/clm_75C93A8D0879.md)
- 2009-12-31 to 2010-03-31 | money | total_assets | 27,460,900,000 United States dollar | superseded | [clm_2EE0E53C5274](/claim/clm_2EE0E53C5274.md)
- 2009-12-31 to 2010-03-31 | money | total_equity | 9,525,300,000 United States dollar | superseded | [clm_2DB2351A5E3F](/claim/clm_2DB2351A5E3F.md)

## 2010

- 2010-02-12 to 2010-04-20 | money | shares_outstanding | 1,153,145,432 shares | superseded | [clm_E06082706B29](/claim/clm_E06082706B29.md)
- 2010-03-31 to 2010-06-30 | money | cash_and_equivalents | 4,725,200,000 United States dollar | superseded | [clm_23A59C397ADF](/claim/clm_23A59C397ADF.md)
- 2010-03-31 to 2010-06-30 | money | quarterly_net_income | 1,248,100,000 United States dollar | superseded | [clm_517DCA2A54BA](/claim/clm_517DCA2A54BA.md)
- 2010-03-31 to 2010-06-30 | money | quarterly_research_and_development | 1,039,100,000 United States dollar | superseded | [clm_0520A3172746](/claim/clm_0520A3172746.md)
- 2010-03-31 to 2010-06-30 | money | quarterly_revenue | 5,485,500,000 United States dollar | superseded | [clm_8F20DCC9E865](/claim/clm_8F20DCC9E865.md)
- 2010-03-31 to 2010-06-30 | money | total_assets | 27,197,800,000 United States dollar | superseded | [clm_2AC520521790](/claim/clm_2AC520521790.md)
- 2010-03-31 to 2010-06-30 | money | total_equity | 10,462,300,000 United States dollar | superseded | [clm_94E485E9D35E](/claim/clm_94E485E9D35E.md)
- 2010-04-20 to 2010-07-20 | money | shares_outstanding | 1,153,140,541 shares | superseded | [clm_D07BF22B0B77](/claim/clm_D07BF22B0B77.md)
- 2010-06-30 to 2010-09-30 | money | cash_and_equivalents | 5,163,500,000 United States dollar | superseded | [clm_CD4A9AF23672](/claim/clm_CD4A9AF23672.md)
- 2010-06-30 to 2010-09-30 | money | quarterly_net_income | 1,348,900,000 United States dollar | superseded | [clm_B4284D186BEA](/claim/clm_B4284D186BEA.md)
- 2010-06-30 to 2010-09-30 | money | quarterly_research_and_development | 1,187,200,000 United States dollar | superseded | [clm_CA57488E244D](/claim/clm_CA57488E244D.md)
- 2010-06-30 to 2010-09-30 | money | quarterly_revenue | 5,748,700,000 United States dollar | superseded | [clm_A35F7484BB60](/claim/clm_A35F7484BB60.md)
- 2010-06-30 to 2010-09-30 | money | total_assets | 27,723,100,000 United States dollar | superseded | [clm_E442336E02C1](/claim/clm_E442336E02C1.md)
- 2010-06-30 to 2010-09-30 | money | total_equity | 10,235,300,000 United States dollar | superseded | [clm_FBAE96E2C630](/claim/clm_FBAE96E2C630.md)
- 2010-07-20 to 2010-10-20 | money | shares_outstanding | 1,153,140,311 shares | superseded | [clm_2A46B3B6816C](/claim/clm_2A46B3B6816C.md)
- 2010-09-30 to 2010-12-31 | money | cash_and_equivalents | 5,908,800,000 United States dollar | superseded | [clm_D55EB81EF641](/claim/clm_D55EB81EF641.md)
- 2010-09-30 to 2011-03-31 | money | quarterly_net_income | 1,302,900,000 United States dollar | superseded | [clm_37EF8BFF3C1E](/claim/clm_37EF8BFF3C1E.md)
- 2010-09-30 to 2011-03-31 | money | quarterly_research_and_development | 1,219,800,000 United States dollar | superseded | [clm_49B945AD669C](/claim/clm_49B945AD669C.md)
- 2010-09-30 to 2011-03-31 | money | quarterly_revenue | 5,654,800,000 United States dollar | superseded | [clm_4D8CE841EAC1](/claim/clm_4D8CE841EAC1.md)
- 2010-09-30 to 2010-12-31 | money | total_assets | 29,904,300,000 United States dollar | superseded | [clm_57EC22604D75](/claim/clm_57EC22604D75.md)
- 2010-09-30 to 2010-12-31 | money | total_equity | 12,405,500,000 United States dollar | superseded | [clm_A6D50CE13C80](/claim/clm_A6D50CE13C80.md)
- 2010-10-20 to 2011-02-15 | money | shares_outstanding | 1,153,143,311 shares | superseded | [clm_4EF303147BF7](/claim/clm_4EF303147BF7.md)
- 2010-12-31 to 2011-03-31 | money | cash_and_equivalents | 5,993,200,000 United States dollar | superseded | [clm_5A71EDBC0AD2](/claim/clm_5A71EDBC0AD2.md)
- 2010-12-31 to 2011-12-31 | money | net_income | 5,069,500,000 United States dollar | superseded | [clm_4BDBC4365AB7](/claim/clm_4BDBC4365AB7.md)
- 2010-12-31 to 2011-12-31 | money | research_and_development | 4,884,200,000 United States dollar | superseded | [clm_E5BECE5372F5](/claim/clm_E5BECE5372F5.md)
- 2010-12-31 to 2011-12-31 | money | revenue | 23,076,000,000 United States dollar | superseded | [clm_2164E9BDD211](/claim/clm_2164E9BDD211.md)
- 2010-12-31 to 2011-03-31 | money | total_assets | 31,001,400,000 United States dollar | superseded | [clm_4CD8C1030C06](/claim/clm_4CD8C1030C06.md)
- 2010-12-31 to 2011-03-31 | money | total_equity | 12,420,300,000 United States dollar | superseded | [clm_38907029577E](/claim/clm_38907029577E.md)

## 2011

- 2011-02-15 to 2011-04-20 | money | shares_outstanding | 1,157,664,779 shares | superseded | [clm_2EAD3D4E1CDB](/claim/clm_2EAD3D4E1CDB.md)
- 2011-03-31 to 2011-06-30 | money | cash_and_equivalents | 6,506,400,000 United States dollar | superseded | [clm_A1E24BDCAA75](/claim/clm_A1E24BDCAA75.md)
- 2011-03-31 to 2011-06-30 | money | quarterly_net_income | 1,055,900,000 United States dollar | superseded | [clm_444313C9661E](/claim/clm_444313C9661E.md)
- 2011-03-31 to 2011-06-30 | money | quarterly_research_and_development | 1,124,000,000 United States dollar | superseded | [clm_B28901D6C9E0](/claim/clm_B28901D6C9E0.md)
- 2011-03-31 to 2011-06-30 | money | quarterly_revenue | 5,839,200,000 United States dollar | superseded | [clm_D8537173D284](/claim/clm_D8537173D284.md)
- 2011-03-31 to 2011-06-30 | money | total_assets | 31,695,300,000 United States dollar | superseded | [clm_5A450E7581A9](/claim/clm_5A450E7581A9.md)
- 2011-03-31 to 2011-06-30 | money | total_equity | 13,934,200,000 United States dollar | superseded | [clm_F3231A21A793](/claim/clm_F3231A21A793.md)
- 2011-04-20 to 2011-07-20 | money | shares_outstanding | 1,157,666,449 shares | superseded | [clm_6A827F1F7429](/claim/clm_6A827F1F7429.md)
- 2011-06-30 to 2011-09-30 | money | cash_and_equivalents | 6,113,500,000 United States dollar | superseded | [clm_B2819CA11725](/claim/clm_B2819CA11725.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_net_income | 1,197,300,000 United States dollar | superseded | [clm_008FDC208224](/claim/clm_008FDC208224.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_research_and_development | 1,260,600,000 United States dollar | superseded | [clm_8B1DF12BB663](/claim/clm_8B1DF12BB663.md)
- 2011-06-30 to 2011-09-30 | money | quarterly_revenue | 6,252,800,000 United States dollar | superseded | [clm_DC301C0F7A36](/claim/clm_DC301C0F7A36.md)
- 2011-06-30 to 2011-09-30 | money | total_assets | 32,779,300,000 United States dollar | superseded | [clm_56266631D4EB](/claim/clm_56266631D4EB.md)
- 2011-06-30 to 2011-09-30 | money | total_equity | 14,277,000,000 United States dollar | superseded | [clm_04056C4340A0](/claim/clm_04056C4340A0.md)
- 2011-07-20 to 2011-10-20 | money | shares_outstanding | 1,157,688,685 shares | superseded | [clm_BC1F6D19D227](/claim/clm_BC1F6D19D227.md)
- 2011-09-30 to 2011-12-31 | money | cash_and_equivalents | 6,597,700,000 United States dollar | superseded | [clm_791E44413C99](/claim/clm_791E44413C99.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_net_income | 1,236,300,000 United States dollar | superseded | [clm_354B7C6D61E5](/claim/clm_354B7C6D61E5.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_research_and_development | 1,280,900,000 United States dollar | superseded | [clm_62421650D215](/claim/clm_62421650D215.md)
- 2011-09-30 to 2012-03-31 | money | quarterly_revenue | 6,147,900,000 United States dollar | superseded | [clm_8942550E1D13](/claim/clm_8942550E1D13.md)
- 2011-09-30 to 2011-12-31 | money | total_assets | 33,042,200,000 United States dollar | superseded | [clm_8A478ABF3F11](/claim/clm_8A478ABF3F11.md)
- 2011-09-30 to 2011-12-31 | money | total_equity | 15,057,900,000 United States dollar | superseded | [clm_46A4D8518C6C](/claim/clm_46A4D8518C6C.md)
- 2011-10-20 to 2012-02-15 | money | shares_outstanding | 1,157,762,135 shares | superseded | [clm_8D6F78B317FE](/claim/clm_8D6F78B317FE.md)
- 2011-12-31 to 2012-03-31 | money | cash_and_equivalents | 5,922,500,000 United States dollar | superseded | [clm_1B2574BD7DC9](/claim/clm_1B2574BD7DC9.md)
- 2011-12-31 to 2012-12-31 | money | net_income | 4,347,700,000 United States dollar | superseded | [clm_7E497C262CA8](/claim/clm_7E497C262CA8.md)
- 2011-12-31 to 2012-12-31 | money | research_and_development | 5,020,800,000 United States dollar | superseded | [clm_965E7901CE0F](/claim/clm_965E7901CE0F.md)
- 2011-12-31 to 2012-12-31 | money | revenue | 24,286,500,000 United States dollar | superseded | [clm_BF9624252D1F](/claim/clm_BF9624252D1F.md)
- 2011-12-31 to 2012-03-31 | money | total_assets | 33,659,800,000 United States dollar | superseded | [clm_A0CD20471FEE](/claim/clm_A0CD20471FEE.md)
- 2011-12-31 to 2012-03-31 | money | total_equity | 13,541,700,000 United States dollar | superseded | [clm_4C30A8195523](/claim/clm_4C30A8195523.md)

## 2012

- 2012-02-15 to 2012-04-20 | money | shares_outstanding | 1,160,406,840 shares | superseded | [clm_98D3F4CB333B](/claim/clm_98D3F4CB333B.md)
- 2012-03-31 to 2012-06-30 | money | cash_and_equivalents | 4,122,200,000 United States dollar | superseded | [clm_536151C257D4](/claim/clm_536151C257D4.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_net_income | 1,011,100,000 United States dollar | superseded | [clm_DDE62BAA81E2](/claim/clm_DDE62BAA81E2.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_research_and_development | 1,151,500,000 United States dollar | superseded | [clm_484485049F9B](/claim/clm_484485049F9B.md)
- 2012-03-31 to 2012-06-30 | money | quarterly_revenue | 5,602,000,000 United States dollar | superseded | [clm_7903628E4764](/claim/clm_7903628E4764.md)
- 2012-03-31 to 2012-06-30 | money | total_assets | 32,238,200,000 United States dollar | superseded | [clm_74CB0764DE87](/claim/clm_74CB0764DE87.md)
- 2012-03-31 to 2012-06-30 | money | total_equity | 14,822,600,000 United States dollar | superseded | [clm_0229E1C0F88C](/claim/clm_0229E1C0F88C.md)
- 2012-04-20 to 2012-07-20 | money | shares_outstanding | 1,160,415,307 shares | superseded | [clm_DAEB0FB8113F](/claim/clm_DAEB0FB8113F.md)
- 2012-06-30 to 2012-09-30 | money | cash_and_equivalents | 4,345,800,000 United States dollar | superseded | [clm_026D54438B59](/claim/clm_026D54438B59.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_net_income | 923,600,000 United States dollar | superseded | [clm_FD077BD0D902](/claim/clm_FD077BD0D902.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_research_and_development | 1,320,700,000 United States dollar | superseded | [clm_60F07D90B8A9](/claim/clm_60F07D90B8A9.md)
- 2012-06-30 to 2012-09-30 | money | quarterly_revenue | 5,600,700,000 United States dollar | superseded | [clm_5DAD0E6A0EE5](/claim/clm_5DAD0E6A0EE5.md)
- 2012-06-30 to 2012-09-30 | money | total_assets | 31,812,600,000 United States dollar | superseded | [clm_99236EECA95B](/claim/clm_99236EECA95B.md)
- 2012-06-30 to 2012-09-30 | money | total_equity | 14,307,900,000 United States dollar | superseded | [clm_66BC72EF2E29](/claim/clm_66BC72EF2E29.md)
- 2012-07-20 to 2012-10-20 | money | shares_outstanding | 1,160,425,459 shares | superseded | [clm_E5115E989619](/claim/clm_E5115E989619.md)
- 2012-09-30 to 2012-12-31 | money | cash_and_equivalents | 5,319,200,000 United States dollar | superseded | [clm_E6EA3ECD40CD](/claim/clm_E6EA3ECD40CD.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_net_income | 1,326,600,000 United States dollar | superseded | [clm_326641396B5E](/claim/clm_326641396B5E.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_research_and_development | 1,342,800,000 United States dollar | superseded | [clm_916A4076C233](/claim/clm_916A4076C233.md)
- 2012-09-30 to 2013-03-31 | money | quarterly_revenue | 5,443,300,000 United States dollar | superseded | [clm_911654133F1A](/claim/clm_911654133F1A.md)
- 2012-09-30 to 2012-12-31 | money | total_assets | 34,321,000,000 United States dollar | superseded | [clm_485295C4EFF2](/claim/clm_485295C4EFF2.md)
- 2012-09-30 to 2012-12-31 | money | total_equity | 16,056,900,000 United States dollar | superseded | [clm_F69758EEF222](/claim/clm_F69758EEF222.md)
- 2012-10-20 to 2013-02-15 | money | shares_outstanding | 1,160,452,507 shares | superseded | [clm_68696D5895F1](/claim/clm_68696D5895F1.md)
- 2012-12-31 to 2013-03-31 | money | cash_and_equivalents | 4,018,800,000 United States dollar | superseded | [clm_2B4A9BAB1058](/claim/clm_2B4A9BAB1058.md)
- 2012-12-31 to 2013-12-31 | money | net_income | 4,088,600,000 United States dollar | superseded | [clm_592E3DCB062C](/claim/clm_592E3DCB062C.md)
- 2012-12-31 to 2013-12-31 | money | research_and_development | 5,278,100,000 United States dollar | superseded | [clm_1B4BD9A59709](/claim/clm_1B4BD9A59709.md)
- 2012-12-31 to 2013-12-31 | money | revenue | 22,603,400,000 United States dollar | superseded | [clm_8E230B90B165](/claim/clm_8E230B90B165.md)
- 2012-12-31 to 2013-03-31 | money | total_assets | 34,398,900,000 United States dollar | superseded | [clm_CB104F41D380](/claim/clm_CB104F41D380.md)
- 2012-12-31 to 2013-03-31 | money | total_equity | 14,765,200,000 United States dollar | superseded | [clm_FB9C859803DD](/claim/clm_FB9C859803DD.md)

## 2013

- 2013-02-15 to 2013-04-20 | money | shares_outstanding | 1,134,411,762 shares | superseded | [clm_31DF8C9FFA10](/claim/clm_31DF8C9FFA10.md)
- 2013-03-31 to 2013-06-30 | money | cash_and_equivalents | 3,936,600,000 United States dollar | superseded | [clm_1F2201F2D0BD](/claim/clm_1F2201F2D0BD.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_net_income | 1,548,000,000 United States dollar | superseded | [clm_D4B25CE8BA78](/claim/clm_D4B25CE8BA78.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_research_and_development | 1,348,100,000 United States dollar | superseded | [clm_D1081C21953D](/claim/clm_D1081C21953D.md)
- 2013-03-31 to 2013-06-30 | money | quarterly_revenue | 5,602,000,000 United States dollar | superseded | [clm_0690B5F615D3](/claim/clm_0690B5F615D3.md)
- 2013-03-31 to 2013-06-30 | money | total_assets | 32,300,100,000 United States dollar | superseded | [clm_F659FE767693](/claim/clm_F659FE767693.md)
- 2013-03-31 to 2013-06-30 | money | total_equity | 14,955,600,000 United States dollar | superseded | [clm_84981FD25199](/claim/clm_84981FD25199.md)
- 2013-04-20 to 2013-07-20 | money | shares_outstanding | 1,126,561,464 shares | superseded | [clm_2ECD2538ABDF](/claim/clm_2ECD2538ABDF.md)
- 2013-06-30 to 2013-09-30 | money | cash_and_equivalents | 3,786,500,000 United States dollar | superseded | [clm_1EFA1709BF1A](/claim/clm_1EFA1709BF1A.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_net_income | 1,206,200,000 United States dollar | superseded | [clm_60291CAA51AF](/claim/clm_60291CAA51AF.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_research_and_development | 1,330,400,000 United States dollar | superseded | [clm_F933691E99F4](/claim/clm_F933691E99F4.md)
- 2013-06-30 to 2013-09-30 | money | quarterly_revenue | 5,929,700,000 United States dollar | superseded | [clm_3FC6922ADF8C](/claim/clm_3FC6922ADF8C.md)
- 2013-06-30 to 2013-09-30 | money | total_assets | 33,226,000,000 United States dollar | superseded | [clm_CBF31B7F88E5](/claim/clm_CBF31B7F88E5.md)
- 2013-06-30 to 2013-09-30 | money | total_equity | 15,236,400,000 United States dollar | superseded | [clm_1701758C9C6B](/claim/clm_1701758C9C6B.md)
- 2013-07-20 to 2013-10-23 | money | shares_outstanding | 1,126,637,846 shares | superseded | [clm_075381BC33FC](/claim/clm_075381BC33FC.md)
- 2013-09-30 to 2013-12-31 | money | cash_and_equivalents | 4,368,900,000 United States dollar | superseded | [clm_AA58254D76F9](/claim/clm_AA58254D76F9.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_net_income | 1,203,100,000 United States dollar | superseded | [clm_BFE79E4C8CBA](/claim/clm_BFE79E4C8CBA.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_research_and_development | 1,377,400,000 United States dollar | superseded | [clm_4E41FE1D526A](/claim/clm_4E41FE1D526A.md)
- 2013-09-30 to 2014-03-31 | money | quarterly_revenue | 5,772,600,000 United States dollar | superseded | [clm_843FCDB40589](/claim/clm_843FCDB40589.md)
- 2013-09-30 to 2013-12-31 | money | total_assets | 33,965,600,000 United States dollar | superseded | [clm_39E899BCF868](/claim/clm_39E899BCF868.md)
- 2013-09-30 to 2013-12-31 | money | total_equity | 16,896,100,000 United States dollar | superseded | [clm_EEEAB419DCCD](/claim/clm_EEEAB419DCCD.md)
- 2013-10-23 to 2014-02-14 | money | shares_outstanding | 1,126,649,615 shares | superseded | [clm_68E1EE01EC17](/claim/clm_68E1EE01EC17.md)
- 2013-12-31 to 2014-03-31 | money | cash_and_equivalents | 3,830,200,000 United States dollar | superseded | [clm_2F65246E9FDA](/claim/clm_2F65246E9FDA.md)
- 2013-12-31 to 2014-12-31 | money | net_income | 4,684,800,000 United States dollar | superseded | [clm_172E66143A90](/claim/clm_172E66143A90.md)
- 2013-12-31 to 2014-12-31 | money | research_and_development | 5,531,300,000 United States dollar | superseded | [clm_ADD13B3620DD](/claim/clm_ADD13B3620DD.md)
- 2013-12-31 to 2014-12-31 | money | revenue | 23,113,100,000 United States dollar | superseded | [clm_8F9AC59BE835](/claim/clm_8F9AC59BE835.md)
- 2013-12-31 to 2014-03-31 | money | total_assets | 35,248,700,000 United States dollar | superseded | [clm_5BEEA4B8561C](/claim/clm_5BEEA4B8561C.md)
- 2013-12-31 to 2014-03-31 | money | total_equity | 17,631,400,000 United States dollar | superseded | [clm_449F1D02A97D](/claim/clm_449F1D02A97D.md)

## 2014

- 2014-02-14 to 2014-04-21 | money | shares_outstanding | 1,119,713,084 shares | superseded | [clm_D846AC4397FC](/claim/clm_D846AC4397FC.md)
- 2014-03-31 to 2014-06-30 | money | cash_and_equivalents | 3,888,000,000 United States dollar | superseded | [clm_51D0379CC24E](/claim/clm_51D0379CC24E.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_net_income | 727,900,000 United States dollar | superseded | [clm_358CB722EF06](/claim/clm_358CB722EF06.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_research_and_development | 1,109,300,000 United States dollar | superseded | [clm_2E0D01292DDE](/claim/clm_2E0D01292DDE.md)
- 2014-03-31 to 2014-06-30 | money | quarterly_revenue | 4,683,100,000 United States dollar | superseded | [clm_E805A9930871](/claim/clm_E805A9930871.md)
- 2014-03-31 to 2014-06-30 | money | total_assets | 34,756,900,000 United States dollar | superseded | [clm_9DDA60F84708](/claim/clm_9DDA60F84708.md)
- 2014-03-31 to 2014-06-30 | money | total_equity | 18,338,100,000 United States dollar | superseded | [clm_06455B93E953](/claim/clm_06455B93E953.md)
- 2014-04-21 to 2014-07-21 | money | shares_outstanding | 1,119,451,042 shares | superseded | [clm_9F6D0BBC5F93](/claim/clm_9F6D0BBC5F93.md)
- 2014-06-30 to 2014-09-30 | money | cash_and_equivalents | 3,765,700,000 United States dollar | superseded | [clm_7B542E4AE18B](/claim/clm_7B542E4AE18B.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_net_income | 733,500,000 United States dollar | superseded | [clm_78EB084A9EA9](/claim/clm_78EB084A9EA9.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_research_and_development | 1,195,400,000 United States dollar | superseded | [clm_4659F2118ED9](/claim/clm_4659F2118ED9.md)
- 2014-06-30 to 2014-09-30 | money | quarterly_revenue | 4,935,600,000 United States dollar | superseded | [clm_104129ED0A97](/claim/clm_104129ED0A97.md)
- 2014-06-30 to 2014-09-30 | money | total_assets | 35,018,400,000 United States dollar | superseded | [clm_FB670F4A5538](/claim/clm_FB670F4A5538.md)
- 2014-06-30 to 2014-09-30 | money | total_equity | 17,983,700,000 United States dollar | superseded | [clm_BA7FB06172CD](/claim/clm_BA7FB06172CD.md)
- 2014-07-21 to 2014-10-20 | money | shares_outstanding | 1,117,308,330 shares | superseded | [clm_11E3240141BF](/claim/clm_11E3240141BF.md)
- 2014-09-30 to 2014-12-31 | money | cash_and_equivalents | 3,165,800,000 United States dollar | superseded | [clm_B3A15581AD33](/claim/clm_B3A15581AD33.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_net_income | 500,600,000 United States dollar | superseded | [clm_9A91A4856B27](/claim/clm_9A91A4856B27.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_research_and_development | 1,243,200,000 United States dollar | superseded | [clm_FBB910195E3D](/claim/clm_FBB910195E3D.md)
- 2014-09-30 to 2015-03-31 | money | quarterly_revenue | 4,875,600,000 United States dollar | superseded | [clm_19B3061EB704](/claim/clm_19B3061EB704.md)
- 2014-09-30 to 2014-12-31 | money | total_assets | 34,648,800,000 United States dollar | superseded | [clm_47020DB33D7E](/claim/clm_47020DB33D7E.md)
- 2014-09-30 to 2014-12-31 | money | total_equity | 17,669,300,000 United States dollar | superseded | [clm_570B41055A07](/claim/clm_570B41055A07.md)
- 2014-10-20 to 2015-02-13 | money | shares_outstanding | 1,113,429,817 shares | superseded | [clm_5E5FEE19FF6E](/claim/clm_5E5FEE19FF6E.md)
- 2014-12-31 to 2015-03-31 | money | cash_and_equivalents | 3,871,600,000 United States dollar | superseded | [clm_7595457A53B3](/claim/clm_7595457A53B3.md)
- 2014-12-31 to 2015-12-31 | money | net_income | 2,390,500,000 United States dollar | superseded | [clm_822B542164C0](/claim/clm_822B542164C0.md)
- 2014-12-31 to 2015-12-31 | money | research_and_development | 4,733,600,000 United States dollar | superseded | [clm_8C0CCBB2961E](/claim/clm_8C0CCBB2961E.md)
- 2014-12-31 to 2015-12-31 | money | revenue | 19,615,600,000 United States dollar | superseded | [clm_931AAE69B168](/claim/clm_931AAE69B168.md)
- 2014-12-31 to 2015-03-31 | money | total_assets | 37,178,200,000 United States dollar | superseded | [clm_FB9524B17425](/claim/clm_FB9524B17425.md)
- 2014-12-31 to 2015-03-31 | money | total_equity | 15,373,200,000 United States dollar | superseded | [clm_1643AAEFAE6E](/claim/clm_1643AAEFAE6E.md)

## 2015

- 2015-02-13 to 2015-04-20 | money | shares_outstanding | 1,111,103,942 shares | superseded | [clm_5645E18EB230](/claim/clm_5645E18EB230.md)
- 2015-03-31 to 2015-06-30 | money | cash_and_equivalents | 3,064,800,000 United States dollar | superseded | [clm_8290EEB5A3E8](/claim/clm_8290EEB5A3E8.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_net_income | 529,500,000 United States dollar | superseded | [clm_69787323BA17](/claim/clm_69787323BA17.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_research_and_development | 1,039,300,000 United States dollar | superseded | [clm_F4A8EF5F8415](/claim/clm_F4A8EF5F8415.md)
- 2015-03-31 to 2015-06-30 | money | quarterly_revenue | 4,644,700,000 United States dollar | superseded | [clm_5E48B7152576](/claim/clm_5E48B7152576.md)
- 2015-03-31 to 2015-06-30 | money | total_assets | 35,653,900,000 United States dollar | superseded | [clm_619A4B786053](/claim/clm_619A4B786053.md)
- 2015-03-31 to 2015-06-30 | money | total_equity | 14,919,800,000 United States dollar | superseded | [clm_63D5F3BF0AB6](/claim/clm_63D5F3BF0AB6.md)
- 2015-04-20 to 2015-07-20 | money | shares_outstanding | 1,109,741,140 shares | superseded | [clm_CD315B6AC013](/claim/clm_CD315B6AC013.md)
- 2015-06-30 to 2015-09-30 | money | cash_and_equivalents | 3,315,500,000 United States dollar | superseded | [clm_37260443EDA4](/claim/clm_37260443EDA4.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_net_income | 600,800,000 United States dollar | superseded | [clm_AA212525ACD8](/claim/clm_AA212525ACD8.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_research_and_development | 1,169,500,000 United States dollar | superseded | [clm_6CB072A7991A](/claim/clm_6CB072A7991A.md)
- 2015-06-30 to 2015-09-30 | money | quarterly_revenue | 4,978,700,000 United States dollar | superseded | [clm_F15C91D955BE](/claim/clm_F15C91D955BE.md)
- 2015-06-30 to 2015-09-30 | money | total_assets | 36,036,600,000 United States dollar | superseded | [clm_29CF1248110D](/claim/clm_29CF1248110D.md)
- 2015-06-30 to 2015-09-30 | money | total_equity | 14,670,300,000 United States dollar | superseded | [clm_05E3ACEFE9F4](/claim/clm_05E3ACEFE9F4.md)
- 2015-07-20 to 2015-10-19 | money | shares_outstanding | 1,108,540,541 shares | superseded | [clm_BE11DE44FF9B](/claim/clm_BE11DE44FF9B.md)
- 2015-09-30 to 2015-12-31 | money | cash_and_equivalents | 3,238,800,000 United States dollar | superseded | [clm_C5B1D581A796](/claim/clm_C5B1D581A796.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_net_income | 799,700,000 United States dollar | superseded | [clm_BA9581291E40](/claim/clm_BA9581291E40.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_research_and_development | 1,143,400,000 United States dollar | superseded | [clm_A0FDA0736382](/claim/clm_A0FDA0736382.md)
- 2015-09-30 to 2016-03-31 | money | quarterly_revenue | 4,959,700,000 United States dollar | superseded | [clm_AED191B23B0D](/claim/clm_AED191B23B0D.md)
- 2015-09-30 to 2015-12-31 | money | total_assets | 36,304,700,000 United States dollar | superseded | [clm_2828BE832FA8](/claim/clm_2828BE832FA8.md)
- 2015-09-30 to 2015-12-31 | money | total_equity | 15,221,400,000 United States dollar | superseded | [clm_EECD80D1A6CE](/claim/clm_EECD80D1A6CE.md)
- 2015-10-19 to 2016-02-12 | money | shares_outstanding | 1,108,076,549 shares | superseded | [clm_390A800B86E6](/claim/clm_390A800B86E6.md)
- 2015-12-31 to 2016-03-31 | money | cash_and_equivalents | 3,666,400,000 United States dollar | superseded | [clm_87E254B2B673](/claim/clm_87E254B2B673.md)
- 2015-12-31 to 2016-12-31 | money | net_income | 2,408,400,000 United States dollar | superseded | [clm_4EA9C0C3EB44](/claim/clm_4EA9C0C3EB44.md)
- 2015-12-31 to 2016-12-31 | money | research_and_development | 4,796,400,000 United States dollar | superseded | [clm_1B276AE2739D](/claim/clm_1B276AE2739D.md)
- 2015-12-31 to 2016-12-31 | money | revenue | 19,958,700,000 United States dollar | superseded | [clm_53995054E4D5](/claim/clm_53995054E4D5.md)
- 2015-12-31 to 2016-03-31 | money | total_assets | 35,568,900,000 United States dollar | superseded | [clm_3FF278349F90](/claim/clm_3FF278349F90.md)
- 2015-12-31 to 2016-03-31 | money | total_equity | 14,571,300,000 United States dollar | superseded | [clm_49441DF34787](/claim/clm_49441DF34787.md)

## 2016

- 2016-02-12 to 2016-04-18 | money | shares_outstanding | 1,106,093,485 shares | superseded | [clm_954C4C3D7EBE](/claim/clm_954C4C3D7EBE.md)
- 2016-03-31 to 2016-06-30 | money | cash_and_equivalents | 2,307,600,000 United States dollar | superseded | [clm_FA870C5AC561](/claim/clm_FA870C5AC561.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_net_income | 440,100,000 United States dollar | superseded | [clm_F4315B9F6A7A](/claim/clm_F4315B9F6A7A.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_research_and_development | 1,221,000,000 United States dollar | superseded | [clm_0515A159428D](/claim/clm_0515A159428D.md)
- 2016-03-31 to 2016-06-30 | money | quarterly_revenue | 4,865,100,000 United States dollar | superseded | [clm_1F4EC3A3B4D5](/claim/clm_1F4EC3A3B4D5.md)
- 2016-03-31 to 2016-06-30 | money | total_assets | 34,691,800,000 United States dollar | superseded | [clm_35074E027D38](/claim/clm_35074E027D38.md)
- 2016-03-31 to 2016-06-30 | money | total_equity | 15,009,900,000 United States dollar | superseded | [clm_98CA7C046AF8](/claim/clm_98CA7C046AF8.md)
- 2016-04-18 to 2016-07-18 | money | shares_outstanding | 1,103,837,002 shares | superseded | [clm_29E5B3F2C398](/claim/clm_29E5B3F2C398.md)
- 2016-06-30 to 2016-09-30 | money | cash_and_equivalents | 3,238,000,000 United States dollar | superseded | [clm_AF8251DBBE60](/claim/clm_AF8251DBBE60.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_net_income | 747,700,000 United States dollar | superseded | [clm_3D04484E2898](/claim/clm_3D04484E2898.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_research_and_development | 1,335,900,000 United States dollar | superseded | [clm_E31AD6E2CA61](/claim/clm_E31AD6E2CA61.md)
- 2016-06-30 to 2016-09-30 | money | quarterly_revenue | 5,404,800,000 United States dollar | superseded | [clm_72B1497E5670](/claim/clm_72B1497E5670.md)
- 2016-06-30 to 2016-09-30 | money | total_assets | 36,475,300,000 United States dollar | superseded | [clm_C7DDD74DF355](/claim/clm_C7DDD74DF355.md)
- 2016-06-30 to 2016-09-30 | money | total_equity | 14,637,300,000 United States dollar | superseded | [clm_C85B54CB3609](/claim/clm_C85B54CB3609.md)
- 2016-07-18 to 2016-10-17 | money | shares_outstanding | 1,103,843,444 shares | superseded | [clm_0398CFEE2BD5](/claim/clm_0398CFEE2BD5.md)
- 2016-09-30 to 2016-12-31 | money | cash_and_equivalents | 3,489,000,000 United States dollar | superseded | [clm_8A112E3D2238](/claim/clm_8A112E3D2238.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_net_income | 778,000,000 United States dollar | superseded | [clm_5525F074C916](/claim/clm_5525F074C916.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_research_and_development | 1,236,400,000 United States dollar | superseded | [clm_A8E893E76F87](/claim/clm_A8E893E76F87.md)
- 2016-09-30 to 2017-03-31 | money | quarterly_revenue | 5,191,700,000 United States dollar | superseded | [clm_ADD269D8EB64](/claim/clm_ADD269D8EB64.md)
- 2016-09-30 to 2016-12-31 | money | total_assets | 37,590,300,000 United States dollar | superseded | [clm_A1847770D205](/claim/clm_A1847770D205.md)
- 2016-09-30 to 2016-12-31 | money | total_equity | 15,589,200,000 United States dollar | superseded | [clm_7EE1B4067292](/claim/clm_7EE1B4067292.md)
- 2016-10-17 to 2017-02-13 | money | shares_outstanding | 1,103,948,230 shares | superseded | [clm_49EBF0007D5C](/claim/clm_49EBF0007D5C.md)
- 2016-12-31 to 2017-03-31 | money | cash_and_equivalents | 4,582,100,000 United States dollar | superseded | [clm_97CE4D7A5431](/claim/clm_97CE4D7A5431.md)
- 2016-12-31 to 2017-12-31 | money | net_income | 2,737,600,000 United States dollar | superseded | [clm_ECD98570FDF4](/claim/clm_ECD98570FDF4.md)
- 2016-12-31 to 2017-12-31 | money | research_and_development | 5,243,900,000 United States dollar | superseded | [clm_6D0F6FB5867B](/claim/clm_6D0F6FB5867B.md)
- 2016-12-31 to 2017-12-31 | money | revenue | 21,222,100,000 United States dollar | superseded | [clm_09B0FB69C967](/claim/clm_09B0FB69C967.md)
- 2016-12-31 to 2017-03-31 | money | total_assets | 38,805,900,000 United States dollar | superseded | [clm_DCAB670958F3](/claim/clm_DCAB670958F3.md)
- 2016-12-31 to 2017-03-31 | money | total_equity | 14,007,700,000 United States dollar | superseded | [clm_0A273F2F1080](/claim/clm_0A273F2F1080.md)

## 2017

- 2017-02-13 to 2017-04-24 | money | shares_outstanding | 1,103,352,450 shares | superseded | [clm_ABD29EC217BC](/claim/clm_ABD29EC217BC.md)
- 2017-03-31 to 2017-06-30 | money | cash_and_equivalents | 2,616,900,000 United States dollar | superseded | [clm_BF2787D27F9E](/claim/clm_BF2787D27F9E.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_net_income | -110,800,000 United States dollar | superseded | [clm_204BF56894A9](/claim/clm_204BF56894A9.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_research_and_development | 1,238,300,000 United States dollar | superseded | [clm_B519477BC9FD](/claim/clm_B519477BC9FD.md)
- 2017-03-31 to 2017-06-30 | money | quarterly_revenue | 5,228,300,000 United States dollar | superseded | [clm_038044B3B9B8](/claim/clm_038044B3B9B8.md)
- 2017-03-31 to 2017-06-30 | money | total_assets | 37,624,300,000 United States dollar | superseded | [clm_EF50813461C3](/claim/clm_EF50813461C3.md)
- 2017-03-31 to 2017-06-30 | money | total_equity | 14,031,000,000 United States dollar | superseded | [clm_44091369BB0F](/claim/clm_44091369BB0F.md)
- 2017-04-24 to 2017-07-17 | money | shares_outstanding | 1,103,388,743 shares | superseded | [clm_4C12B1C9DF34](/claim/clm_4C12B1C9DF34.md)
- 2017-06-30 to 2017-09-30 | money | cash_and_equivalents | 3,069,900,000 United States dollar | superseded | [clm_38F458D1BB00](/claim/clm_38F458D1BB00.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_net_income | 1,008,000,000 United States dollar | superseded | [clm_04082787F8B3](/claim/clm_04082787F8B3.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_research_and_development | 1,250,900,000 United States dollar | superseded | [clm_930CA1B90992](/claim/clm_930CA1B90992.md)
- 2017-06-30 to 2017-09-30 | money | quarterly_revenue | 5,824,300,000 United States dollar | superseded | [clm_1D6AC1DB5DDA](/claim/clm_1D6AC1DB5DDA.md)
- 2017-06-30 to 2017-09-30 | money | total_assets | 40,946,500,000 United States dollar | superseded | [clm_9BAE6ED0A697](/claim/clm_9BAE6ED0A697.md)
- 2017-06-30 to 2017-09-30 | money | total_equity | 14,100,800,000 United States dollar | superseded | [clm_3C0A3B01161E](/claim/clm_3C0A3B01161E.md)
- 2017-07-17 to 2017-10-23 | money | shares_outstanding | 1,100,988,944 shares | superseded | [clm_BB222876F045](/claim/clm_BB222876F045.md)
- 2017-09-30 to 2017-12-31 | money | cash_and_equivalents | 3,724,300,000 United States dollar | superseded | [clm_7B8BDD309F9A](/claim/clm_7B8BDD309F9A.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_net_income | 555,600,000 United States dollar | superseded | [clm_F933C58020E5](/claim/clm_F933C58020E5.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_research_and_development | 1,319,400,000 United States dollar | superseded | [clm_4BBDB8977EFF](/claim/clm_4BBDB8977EFF.md)
- 2017-09-30 to 2018-03-31 | money | quarterly_revenue | 5,658,000,000 United States dollar | superseded | [clm_5FD91BF932E6](/claim/clm_5FD91BF932E6.md)
- 2017-09-30 to 2017-12-31 | money | total_assets | 43,010,400,000 United States dollar | superseded | [clm_C299504341FF](/claim/clm_C299504341FF.md)
- 2017-09-30 to 2017-12-31 | money | total_equity | 14,890,300,000 United States dollar | superseded | [clm_6016D10EB1D9](/claim/clm_6016D10EB1D9.md)
- 2017-10-23 to 2018-02-14 | money | shares_outstanding | 1,101,094,711 shares | superseded | [clm_D59D78AA6954](/claim/clm_D59D78AA6954.md)
- 2017-12-31 to 2018-03-31 | money | cash_and_equivalents | 6,536,200,000 United States dollar | superseded | [clm_7B8D449B4862](/claim/clm_7B8D449B4862.md)
- 2017-12-31 to 2018-12-31 | money | net_income | -204,100,000 United States dollar | superseded | [clm_A49582D43487](/claim/clm_A49582D43487.md)
- 2017-12-31 to 2018-12-31 | money | research_and_development | 5,281,800,000 United States dollar | superseded | [clm_1D6D085414BC](/claim/clm_1D6D085414BC.md)
- 2017-12-31 to 2018-12-31 | money | revenue | 22,871,300,000 United States dollar | superseded | [clm_0C495BD0FBE4](/claim/clm_0C495BD0FBE4.md)
- 2017-12-31 to 2018-03-31 | money | total_assets | 44,981,000,000 United States dollar | superseded | [clm_9463DD58F180](/claim/clm_9463DD58F180.md)
- 2017-12-31 to 2018-03-31 | money | total_equity | 11,592,200,000 United States dollar | superseded | [clm_C9D7EC5AA793](/claim/clm_C9D7EC5AA793.md)

## 2018

- 2018-02-14 to 2018-04-23 | money | shares_outstanding | 1,095,597,580 shares | superseded | [clm_89BF6F9A0371](/claim/clm_89BF6F9A0371.md)
- 2018-03-31 to 2018-06-30 | money | cash_and_equivalents | 3,084,300,000 United States dollar | superseded | [clm_F28DDDE756C5](/claim/clm_F28DDDE756C5.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_net_income | 1,217,400,000 United States dollar | superseded | [clm_D7E9283EA9D1](/claim/clm_D7E9283EA9D1.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_research_and_development | 1,176,900,000 United States dollar | superseded | [clm_5F2AD88EFADC](/claim/clm_5F2AD88EFADC.md)
- 2018-03-31 to 2018-06-30 | money | quarterly_revenue | 5,700,000,000 United States dollar | superseded | [clm_2064AA6387A6](/claim/clm_2064AA6387A6.md)
- 2018-03-31 to 2018-06-30 | money | total_assets | 44,355,600,000 United States dollar | superseded | [clm_03A59D1CFECD](/claim/clm_03A59D1CFECD.md)
- 2018-03-31 to 2018-06-30 | money | total_equity | 14,527,000,000 United States dollar | superseded | [clm_1F8EC1251DE2](/claim/clm_1F8EC1251DE2.md)
- 2018-04-23 to 2018-07-23 | money | shares_outstanding | 1,085,430,420 shares | superseded | [clm_ECF7FEC12945](/claim/clm_ECF7FEC12945.md)
- 2018-06-30 to 2018-09-30 | money | cash_and_equivalents | 6,817,300,000 United States dollar | superseded | [clm_AF6D10B3DE1F](/claim/clm_AF6D10B3DE1F.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_net_income | -259,900,000 United States dollar | superseded | [clm_38DEDDCE8663](/claim/clm_38DEDDCE8663.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_research_and_development | 1,333,100,000 United States dollar | superseded | [clm_B3200D4A3CEB](/claim/clm_B3200D4A3CEB.md)
- 2018-06-30 to 2018-09-30 | money | quarterly_revenue | 6,355,200,000 United States dollar | superseded | [clm_F2315229046E](/claim/clm_F2315229046E.md)
- 2018-06-30 to 2018-09-30 | money | total_assets | 42,359,200,000 United States dollar | superseded | [clm_D6B2544E9EB7](/claim/clm_D6B2544E9EB7.md)
- 2018-06-30 to 2018-09-30 | money | total_equity | 11,555,200,000 United States dollar | superseded | [clm_E89D6F88DF2A](/claim/clm_E89D6F88DF2A.md)
- 2018-07-23 to 2018-11-02 | money | shares_outstanding | 1,073,987,856 shares | superseded | [clm_B41B2FCF04EB](/claim/clm_B41B2FCF04EB.md)
- 2018-09-30 to 2018-12-31 | money | cash_and_equivalents | 8,960,000,000 United States dollar | superseded | [clm_C653C5087E4A](/claim/clm_C653C5087E4A.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_net_income | 1,149,500,000 United States dollar | superseded | [clm_A0296B1474AD](/claim/clm_A0296B1474AD.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_research_and_development | 1,343,300,000 United States dollar | superseded | [clm_ED58AC0EB4EB](/claim/clm_ED58AC0EB4EB.md)
- 2018-09-30 to 2019-03-31 | money | quarterly_revenue | 6,061,900,000 United States dollar | superseded | [clm_FE144E331568](/claim/clm_FE144E331568.md)
- 2018-09-30 to 2018-12-31 | money | total_assets | 44,625,100,000 United States dollar | superseded | [clm_7683EC843B20](/claim/clm_7683EC843B20.md)
- 2018-09-30 to 2018-12-31 | money | total_equity | 13,076,600,000 United States dollar | superseded | [clm_0EDBC9C09148](/claim/clm_0EDBC9C09148.md)
- 2018-11-02 to 2019-02-13 | money | shares_outstanding | 1,059,322,255 shares | superseded | [clm_7D2CCF7691F5](/claim/clm_7D2CCF7691F5.md)
- 2018-12-31 to 2019-03-31 | money | cash_and_equivalents | 7,998,200,000 United States dollar | superseded | [clm_C02D22EACC34](/claim/clm_C02D22EACC34.md)
- 2018-12-31 to 2019-12-31 | money | net_income | 3,232,000,000 United States dollar | superseded | [clm_B5442530014B](/claim/clm_B5442530014B.md)
- 2018-12-31 to 2019-12-31 | money | research_and_development | 5,307,100,000 United States dollar | superseded | [clm_8C3635AEC49A](/claim/clm_8C3635AEC49A.md)
- 2018-12-31 to 2019-12-31 | money | revenue | 24,555,700,000 United States dollar | superseded | [clm_E02BDD0A70F8](/claim/clm_E02BDD0A70F8.md)
- 2018-12-31 to 2019-03-31 | money | total_assets | 43,908,400,000 United States dollar | superseded | [clm_EEDFD1337A30](/claim/clm_EEDFD1337A30.md)
- 2018-12-31 to 2019-03-31 | money | total_equity | 9,828,700,000 United States dollar | superseded | [clm_9BB988E6330F](/claim/clm_9BB988E6330F.md)

## 2019

- 2019-02-13 to 2019-04-29 | money | shares_outstanding | 1,035,418,562 shares | superseded | [clm_6F1E0522B9D9](/claim/clm_6F1E0522B9D9.md)
- 2019-03-31 to 2019-06-30 | money | cash_and_equivalents | 2,036,400,000 United States dollar | superseded | [clm_30B8DAA128A6](/claim/clm_30B8DAA128A6.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_net_income | 4,241,600,000 United States dollar | superseded | [clm_E7362E1D5592](/claim/clm_E7362E1D5592.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_research_and_development | 1,230,500,000 United States dollar | superseded | [clm_48750F1D1FE6](/claim/clm_48750F1D1FE6.md)
- 2019-03-31 to 2019-06-30 | money | quarterly_revenue | 5,092,200,000 United States dollar | superseded | [clm_596A387D969F](/claim/clm_596A387D969F.md)
- 2019-03-31 to 2019-06-30 | money | total_assets | 38,006,800,000 United States dollar | superseded | [clm_95CD25DDBCB9](/claim/clm_95CD25DDBCB9.md)
- 2019-03-31 to 2019-06-30 | money | total_equity | 2,480,300,000 United States dollar | superseded | [clm_AC0198A66E27](/claim/clm_AC0198A66E27.md)
- 2019-04-29 to 2019-07-29 | money | shares_outstanding | 970,830,868 shares | superseded | [clm_04D4986A2A84](/claim/clm_04D4986A2A84.md)
- 2019-06-30 to 2019-12-31 | money | cash_and_equivalents | 2,290,200,000 United States dollar | superseded | [clm_C88149C9C065](/claim/clm_C88149C9C065.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_net_income | 1,327,200,000 United States dollar | superseded | [clm_5FAB4A169B5B](/claim/clm_5FAB4A169B5B.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_research_and_development | 1,402,200,000 United States dollar | superseded | [clm_E28EAAD1FF5D](/claim/clm_E28EAAD1FF5D.md)
- 2019-06-30 to 2019-09-30 | money | quarterly_revenue | 5,636,700,000 United States dollar | superseded | [clm_F113B6E2585B](/claim/clm_F113B6E2585B.md)
- 2019-06-30 to 2019-09-30 | money | total_assets | 38,666,400,000 United States dollar | superseded | [clm_773D2FAE99CC](/claim/clm_773D2FAE99CC.md)
- 2019-06-30 to 2019-09-30 | money | total_equity | 2,780,500,000 United States dollar | superseded | [clm_E2C19C62764F](/claim/clm_E2C19C62764F.md)
- 2019-07-29 to 2019-10-21 | money | shares_outstanding | 965,432,952 shares | superseded | [clm_F82C28C9CB3F](/claim/clm_F82C28C9CB3F.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_net_income | 1,253,900,000 United States dollar | superseded | [clm_EF1A7976A06B](/claim/clm_EF1A7976A06B.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_research_and_development | 1,380,900,000 United States dollar | superseded | [clm_DB9205986489](/claim/clm_DB9205986489.md)
- 2019-09-30 to 2020-03-31 | money | quarterly_revenue | 5,476,600,000 United States dollar | superseded | [clm_645E82FC1A32](/claim/clm_645E82FC1A32.md)
- 2019-09-30 to 2019-12-31 | money | total_assets | 37,893,100,000 United States dollar | superseded | [clm_519C86CA3C31](/claim/clm_519C86CA3C31.md)
- 2019-09-30 to 2019-12-31 | money | total_equity | 3,382,500,000 United States dollar | superseded | [clm_DC02ACC7A380](/claim/clm_DC02ACC7A380.md)
- 2019-10-21 to 2020-02-13 | money | shares_outstanding | 960,130,771 shares | superseded | [clm_47134DBD0A87](/claim/clm_47134DBD0A87.md)
- 2019-10-25 | other | registrant_name | ELI LILLY & Co | valid | [clm_95F26A6CA639](/claim/clm_95F26A6CA639.md)
- 2019-12-31 to 2020-03-31 | money | cash_and_equivalents | 2,337,500,000 United States dollar | superseded | [clm_05C328F5524B](/claim/clm_05C328F5524B.md)
- 2019-12-31 to 2020-12-31 | money | net_income | 8,318,400,000 United States dollar | superseded | [clm_9519CD02B8A4](/claim/clm_9519CD02B8A4.md)
- 2019-12-31 to 2020-12-31 | money | research_and_development | 5,595,000,000 United States dollar | superseded | [clm_7AE5F777CC93](/claim/clm_7AE5F777CC93.md)
- 2019-12-31 to 2020-12-31 | money | revenue | 22,319,500,000 United States dollar | superseded | [clm_BF0371526002](/claim/clm_BF0371526002.md)
- 2019-12-31 to 2020-03-31 | money | total_assets | 39,286,100,000 United States dollar | superseded | [clm_38B67E18082B](/claim/clm_38B67E18082B.md)
- 2019-12-31 to 2020-03-31 | money | total_equity | 2,606,900,000 United States dollar | superseded | [clm_FFAE8DCE11A7](/claim/clm_FFAE8DCE11A7.md)

## 2020

- 2020-02-13 to 2020-04-27 | money | shares_outstanding | 956,382,203 shares | superseded | [clm_0CD54F69E65C](/claim/clm_0CD54F69E65C.md)
- 2020-03-31 to 2020-06-30 | money | cash_and_equivalents | 1,699,000,000 United States dollar | superseded | [clm_6025AF0F4A10](/claim/clm_6025AF0F4A10.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_net_income | 1,456,500,000 United States dollar | superseded | [clm_636432A1644B](/claim/clm_636432A1644B.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_research_and_development | 1,392,100,000 United States dollar | superseded | [clm_F9B6B8A2E8ED](/claim/clm_F9B6B8A2E8ED.md)
- 2020-03-31 to 2020-06-30 | money | quarterly_revenue | 5,859,800,000 United States dollar | superseded | [clm_C179CB065205](/claim/clm_C179CB065205.md)
- 2020-03-31 to 2020-06-30 | money | total_assets | 41,102,800,000 United States dollar | superseded | [clm_39C5B8921781](/claim/clm_39C5B8921781.md)
- 2020-03-31 to 2020-06-30 | money | total_equity | 3,078,800,000 United States dollar | superseded | [clm_1D5999B4B912](/claim/clm_1D5999B4B912.md)
- 2020-04-27 to 2020-07-27 | money | shares_outstanding | 956,450,448 shares | superseded | [clm_B27173165D21](/claim/clm_B27173165D21.md)
- 2020-06-30 to 2020-09-30 | money | cash_and_equivalents | 2,365,100,000 United States dollar | superseded | [clm_6814B9D207EB](/claim/clm_6814B9D207EB.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_net_income | 1,412,000,000 United States dollar | superseded | [clm_65D146DB6B91](/claim/clm_65D146DB6B91.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_research_and_development | 1,390,200,000 United States dollar | superseded | [clm_312F73F4FAFA](/claim/clm_312F73F4FAFA.md)
- 2020-06-30 to 2020-09-30 | money | quarterly_revenue | 5,499,400,000 United States dollar | superseded | [clm_DFC5FB76B4A1](/claim/clm_DFC5FB76B4A1.md)
- 2020-06-30 to 2020-09-30 | money | total_assets | 41,967,000,000 United States dollar | superseded | [clm_A901351CCECE](/claim/clm_A901351CCECE.md)
- 2020-06-30 to 2020-09-30 | money | total_equity | 4,092,900,000 United States dollar | superseded | [clm_7235BBA18F5A](/claim/clm_7235BBA18F5A.md)
- 2020-07-27 to 2020-10-26 | money | shares_outstanding | 956,470,372 shares | superseded | [clm_D0B36FB2290C](/claim/clm_D0B36FB2290C.md)
- 2020-09-30 to 2020-12-31 | money | cash_and_equivalents | 3,595,300,000 United States dollar | superseded | [clm_5345DC3B57B2](/claim/clm_5345DC3B57B2.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_net_income | 1,208,400,000 United States dollar | superseded | [clm_332D40D8A3BD](/claim/clm_332D40D8A3BD.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_research_and_development | 1,465,400,000 United States dollar | superseded | [clm_3C4DC205EF64](/claim/clm_3C4DC205EF64.md)
- 2020-09-30 to 2021-03-31 | money | quarterly_revenue | 5,740,600,000 United States dollar | superseded | [clm_66B1C3D114E4](/claim/clm_66B1C3D114E4.md)
- 2020-09-30 to 2020-12-31 | money | total_assets | 43,946,000,000 United States dollar | superseded | [clm_D92638D7C314](/claim/clm_D92638D7C314.md)
- 2020-09-30 to 2020-12-31 | money | total_equity | 4,826,900,000 United States dollar | superseded | [clm_C8E43F07ABC7](/claim/clm_C8E43F07ABC7.md)
- 2020-10-26 to 2021-02-12 | money | shares_outstanding | 956,581,598 shares | superseded | [clm_8106333AD9A0](/claim/clm_8106333AD9A0.md)
- 2020-12-31 to 2021-03-31 | money | cash_and_equivalents | 3,657,100,000 United States dollar | superseded | [clm_B1E745AC41C4](/claim/clm_B1E745AC41C4.md)
- 2020-12-31 to 2021-12-31 | money | net_income | 6,193,700,000 United States dollar | superseded | [clm_AABFB7142885](/claim/clm_AABFB7142885.md)
- 2020-12-31 to 2021-12-31 | money | research_and_development | 6,085,700,000 United States dollar | superseded | [clm_45941C7F343F](/claim/clm_45941C7F343F.md)
- 2020-12-31 to 2021-12-31 | money | revenue | 24,539,800,000 United States dollar | superseded | [clm_E172D4945A79](/claim/clm_E172D4945A79.md)
- 2020-12-31 to 2021-03-31 | money | total_assets | 46,633,100,000 United States dollar | superseded | [clm_EB972D90100B](/claim/clm_EB972D90100B.md)
- 2020-12-31 to 2021-03-31 | money | total_equity | 5,641,600,000 United States dollar | superseded | [clm_46B4CA545F87](/claim/clm_46B4CA545F87.md)

## 2021

- 2021-02-12 to 2021-04-27 | money | shares_outstanding | 958,425,693 shares | superseded | [clm_4F62576AFF4E](/claim/clm_4F62576AFF4E.md)
- 2021-03-31 to 2021-06-30 | money | cash_and_equivalents | 3,002,400,000 United States dollar | superseded | [clm_0E0B1A8912E6](/claim/clm_0E0B1A8912E6.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_net_income | 1,355,300,000 United States dollar | superseded | [clm_A256AB563F08](/claim/clm_A256AB563F08.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_research_and_development | 1,684,800,000 United States dollar | superseded | [clm_DB9BB042DAB8](/claim/clm_DB9BB042DAB8.md)
- 2021-03-31 to 2021-06-30 | money | quarterly_revenue | 6,805,600,000 United States dollar | superseded | [clm_97459A7EC040](/claim/clm_97459A7EC040.md)
- 2021-03-31 to 2021-06-30 | money | total_assets | 46,838,300,000 United States dollar | superseded | [clm_16B1DF07D73B](/claim/clm_16B1DF07D73B.md)
- 2021-03-31 to 2021-06-30 | money | total_equity | 6,898,700,000 United States dollar | superseded | [clm_FDEFFA86C333](/claim/clm_FDEFFA86C333.md)
- 2021-04-27 to 2021-07-30 | money | shares_outstanding | 959,025,446 shares | superseded | [clm_3086AC877E4A](/claim/clm_3086AC877E4A.md)
- 2021-06-30 to 2021-09-30 | money | cash_and_equivalents | 3,220,000,000 United States dollar | superseded | [clm_8C49EA5286AC](/claim/clm_8C49EA5286AC.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_net_income | 1,390,200,000 United States dollar | superseded | [clm_1BD4CEF67150](/claim/clm_1BD4CEF67150.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_research_and_development | 1,672,800,000 United States dollar | superseded | [clm_261A2B3FF924](/claim/clm_261A2B3FF924.md)
- 2021-06-30 to 2021-09-30 | money | quarterly_revenue | 6,740,100,000 United States dollar | superseded | [clm_77D077A608D2](/claim/clm_77D077A608D2.md)
- 2021-06-30 to 2021-09-30 | money | total_assets | 47,809,000,000 United States dollar | superseded | [clm_47EC471C79DF](/claim/clm_47EC471C79DF.md)
- 2021-06-30 to 2021-09-30 | money | total_equity | 6,444,400,000 United States dollar | superseded | [clm_9D9F1AD72987](/claim/clm_9D9F1AD72987.md)
- 2021-07-30 to 2021-10-22 | money | shares_outstanding | 956,580,893 shares | superseded | [clm_EA59F20B3B9B](/claim/clm_EA59F20B3B9B.md)
- 2021-09-30 to 2021-12-31 | money | cash_and_equivalents | 3,788,200,000 United States dollar | superseded | [clm_1FDCC26FC1A2](/claim/clm_1FDCC26FC1A2.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_net_income | 1,110,100,000 United States dollar | superseded | [clm_462A9B701577](/claim/clm_462A9B701577.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_research_and_development | 1,708,900,000 United States dollar | superseded | [clm_0D1C949297F8](/claim/clm_0D1C949297F8.md)
- 2021-09-30 to 2022-03-31 | money | quarterly_revenue | 6,772,800,000 United States dollar | superseded | [clm_E26527683C4E](/claim/clm_E26527683C4E.md)
- 2021-09-30 to 2021-12-31 | money | total_assets | 48,187,000,000 United States dollar | superseded | [clm_D143A3FF1B0D](/claim/clm_D143A3FF1B0D.md)
- 2021-09-30 to 2021-12-31 | money | total_equity | 7,757,000,000 United States dollar | superseded | [clm_B6A71BBF205E](/claim/clm_B6A71BBF205E.md)
- 2021-10-22 to 2022-02-18 | money | shares_outstanding | 956,592,393 shares | superseded | [clm_AD43BA302B07](/claim/clm_AD43BA302B07.md)
- 2021-12-31 to 2022-03-31 | money | cash_and_equivalents | 3,818,500,000 United States dollar | superseded | [clm_1DE1F8B5A918](/claim/clm_1DE1F8B5A918.md)
- 2021-12-31 to 2022-12-31 | money | net_income | 5,581,700,000 United States dollar | superseded | [clm_BE501ABAA6B4](/claim/clm_BE501ABAA6B4.md)
- 2021-12-31 to 2022-12-31 | money | research_and_development | 7,025,900,000 United States dollar | superseded | [clm_92775F3E7CB5](/claim/clm_92775F3E7CB5.md)
- 2021-12-31 to 2022-12-31 | money | revenue | 28,318,400,000 United States dollar | superseded | [clm_8786FF8AD12B](/claim/clm_8786FF8AD12B.md)
- 2021-12-31 to 2022-03-31 | money | total_assets | 48,806,000,000 United States dollar | superseded | [clm_22AC4E6AFC98](/claim/clm_22AC4E6AFC98.md)
- 2021-12-31 to 2022-03-31 | money | total_equity | 8,979,200,000 United States dollar | superseded | [clm_E4583C178C44](/claim/clm_E4583C178C44.md)

## 2022

- 2022-02-18 to 2022-04-26 | money | shares_outstanding | 952,347,126 shares | superseded | [clm_D784DBD622DB](/claim/clm_D784DBD622DB.md)
- 2022-03-31 to 2022-06-30 | money | cash_and_equivalents | 2,459,200,000 United States dollar | superseded | [clm_0A9E30C747EC](/claim/clm_0A9E30C747EC.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_net_income | 1,902,900,000 United States dollar | superseded | [clm_082E003DAD72](/claim/clm_082E003DAD72.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_research_and_development | 1,610,100,000 United States dollar | superseded | [clm_36AD989DA75C](/claim/clm_36AD989DA75C.md)
- 2022-03-31 to 2022-06-30 | money | quarterly_revenue | 7,810,000,000 United States dollar | superseded | [clm_DB3AB0C80149](/claim/clm_DB3AB0C80149.md)
- 2022-03-31 to 2022-06-30 | money | total_assets | 46,919,300,000 United States dollar | superseded | [clm_5C9CBE97F7BA](/claim/clm_5C9CBE97F7BA.md)
- 2022-03-31 to 2022-06-30 | money | total_equity | 9,330,800,000 United States dollar | superseded | [clm_0575AF1A3F2A](/claim/clm_0575AF1A3F2A.md)
- 2022-04-26 to 2022-08-01 | money | shares_outstanding | 950,159,559 shares | superseded | [clm_D1A1C4F580B5](/claim/clm_D1A1C4F580B5.md)
- 2022-06-30 to 2022-09-30 | money | cash_and_equivalents | 2,622,900,000 United States dollar | superseded | [clm_922A5735F82B](/claim/clm_922A5735F82B.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_net_income | 952,500,000 United States dollar | superseded | [clm_FC303DCB94C7](/claim/clm_FC303DCB94C7.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_research_and_development | 1,781,900,000 United States dollar | superseded | [clm_7E87516D4A1A](/claim/clm_7E87516D4A1A.md)
- 2022-06-30 to 2022-09-30 | money | quarterly_revenue | 6,488,000,000 United States dollar | superseded | [clm_5B96A4E73738](/claim/clm_5B96A4E73738.md)
- 2022-06-30 to 2022-09-30 | money | total_assets | 47,063,600,000 United States dollar | superseded | [clm_B64957C4E2C4](/claim/clm_B64957C4E2C4.md)
- 2022-06-30 to 2022-09-30 | money | total_equity | 8,544,700,000 United States dollar | superseded | [clm_B8A59362EB8C](/claim/clm_B8A59362EB8C.md)
- 2022-08-01 to 2022-10-28 | money | shares_outstanding | 950,174,817 shares | superseded | [clm_C28A879746A6](/claim/clm_C28A879746A6.md)
- 2022-09-30 to 2022-12-31 | money | cash_and_equivalents | 2,617,400,000 United States dollar | superseded | [clm_AC838670E5D3](/claim/clm_AC838670E5D3.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_net_income | 1,451,700,000 United States dollar | superseded | [clm_2B253B0B594C](/claim/clm_2B253B0B594C.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_research_and_development | 1,802,900,000 United States dollar | superseded | [clm_DB412511FD99](/claim/clm_DB412511FD99.md)
- 2022-09-30 to 2023-03-31 | money | quarterly_revenue | 6,941,600,000 United States dollar | superseded | [clm_E29C4C5B9DDD](/claim/clm_E29C4C5B9DDD.md)
- 2022-09-30 to 2022-12-31 | money | total_assets | 47,461,500,000 United States dollar | superseded | [clm_D68B1CE306FC](/claim/clm_D68B1CE306FC.md)
- 2022-09-30 to 2022-12-31 | money | total_equity | 10,070,100,000 United States dollar | superseded | [clm_5FB739309DAD](/claim/clm_5FB739309DAD.md)
- 2022-10-28 to 2023-02-17 | money | shares_outstanding | 950,177,900 shares | superseded | [clm_CEB639753736](/claim/clm_CEB639753736.md)
- 2022-12-31 to 2023-03-31 | money | cash_and_equivalents | 2,067,000,000 United States dollar | superseded | [clm_17A0D356682C](/claim/clm_17A0D356682C.md)
- 2022-12-31 to 2023-12-31 | money | net_income | 6,244,800,000 United States dollar | superseded | [clm_B3346D345CCB](/claim/clm_B3346D345CCB.md)
- 2022-12-31 | money | research_and_development | 7,190,800,000 United States dollar | valid | [clm_B291C97A9E9C](/claim/clm_B291C97A9E9C.md)
- 2022-12-31 to 2023-12-31 | money | revenue | 28,541,400,000 United States dollar | superseded | [clm_4020D18C1AAA](/claim/clm_4020D18C1AAA.md)
- 2022-12-31 to 2023-03-31 | money | total_assets | 49,489,800,000 United States dollar | superseded | [clm_FB4B7491CC72](/claim/clm_FB4B7491CC72.md)
- 2022-12-31 to 2023-03-31 | money | total_equity | 10,649,800,000 United States dollar | superseded | [clm_F3CEC0454BF6](/claim/clm_F3CEC0454BF6.md)

## 2023

- 2023-02-17 to 2023-04-24 | money | shares_outstanding | 950,296,118 shares | superseded | [clm_AFE76CCD74A1](/claim/clm_AFE76CCD74A1.md)
- 2023-03-31 to 2023-06-30 | money | cash_and_equivalents | 3,545,900,000 United States dollar | superseded | [clm_6E2BC5B4F6A4](/claim/clm_6E2BC5B4F6A4.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_net_income | 1,344,900,000 United States dollar | superseded | [clm_9690B63B18DE](/claim/clm_9690B63B18DE.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_research_and_development | 1,985,100,000 United States dollar | superseded | [clm_28ED890F5BBC](/claim/clm_28ED890F5BBC.md)
- 2023-03-31 to 2023-06-30 | money | quarterly_revenue | 6,960,000,000 United States dollar | superseded | [clm_CC9DB32026CE](/claim/clm_CC9DB32026CE.md)
- 2023-03-31 to 2023-06-30 | money | total_assets | 53,163,000,000 United States dollar | superseded | [clm_22782DC05585](/claim/clm_22782DC05585.md)
- 2023-03-31 to 2023-06-30 | money | total_equity | 11,190,400,000 United States dollar | superseded | [clm_94BE166D8C14](/claim/clm_94BE166D8C14.md)
- 2023-04-24 to 2023-08-03 | money | shares_outstanding | 949,272,933 shares | superseded | [clm_31F67D187D33](/claim/clm_31F67D187D33.md)
- 2023-06-30 to 2023-09-30 | money | cash_and_equivalents | 2,694,500,000 United States dollar | superseded | [clm_296654FB728A](/claim/clm_296654FB728A.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_net_income | 1,763,200,000 United States dollar | superseded | [clm_521AF355924A](/claim/clm_521AF355924A.md)
- 2023-06-30 | money | quarterly_research_and_development | 2,356,500,000 United States dollar | valid | [clm_A1B2A03455D9](/claim/clm_A1B2A03455D9.md)
- 2023-06-30 to 2023-09-30 | money | quarterly_revenue | 8,312,100,000 United States dollar | superseded | [clm_D152AA3878B8](/claim/clm_D152AA3878B8.md)
- 2023-06-30 to 2023-09-30 | money | total_assets | 54,814,000,000 United States dollar | superseded | [clm_71063E6D34A8](/claim/clm_71063E6D34A8.md)
- 2023-06-30 to 2023-09-30 | money | total_equity | 11,063,800,000 United States dollar | superseded | [clm_1841AFF1FDCA](/claim/clm_1841AFF1FDCA.md)
- 2023-08-03 to 2023-10-30 | money | shares_outstanding | 949,295,173 shares | superseded | [clm_22F575B45357](/claim/clm_22F575B45357.md)
- 2023-09-30 to 2023-12-31 | money | cash_and_equivalents | 2,380,800,000 United States dollar | superseded | [clm_B4EB7A3B067D](/claim/clm_B4EB7A3B067D.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_net_income | -57,400,000 United States dollar | superseded | [clm_F0A26EC274C3](/claim/clm_F0A26EC274C3.md)
- 2023-09-30 to 2024-03-31 | money | quarterly_revenue | 9,498,600,000 United States dollar | superseded | [clm_3A1E7B4FAF72](/claim/clm_3A1E7B4FAF72.md)
- 2023-09-30 to 2023-12-31 | money | total_assets | 57,915,500,000 United States dollar | superseded | [clm_F973D4A69493](/claim/clm_F973D4A69493.md)
- 2023-09-30 to 2023-12-31 | money | total_equity | 11,220,400,000 United States dollar | superseded | [clm_42DE1899560A](/claim/clm_42DE1899560A.md)
- 2023-10-30 to 2024-02-16 | money | shares_outstanding | 949,307,237 shares | superseded | [clm_AC2092994972](/claim/clm_AC2092994972.md)
- 2023-12-31 to 2024-03-31 | money | cash_and_equivalents | 2,818,600,000 United States dollar | superseded | [clm_C2EC357C8BE0](/claim/clm_C2EC357C8BE0.md)
- 2023-12-31 to 2024-12-31 | money | net_income | 5,240,400,000 United States dollar | superseded | [clm_2C28B4C8BA34](/claim/clm_2C28B4C8BA34.md)
- 2023-12-31 to 2024-12-31 | money | revenue | 34,124,100,000 United States dollar | superseded | [clm_2151D2F15ED6](/claim/clm_2151D2F15ED6.md)
- 2023-12-31 to 2024-03-31 | money | total_assets | 64,006,300,000 United States dollar | superseded | [clm_2E4C08058113](/claim/clm_2E4C08058113.md)
- 2023-12-31 to 2024-03-31 | money | total_equity | 10,771,900,000 United States dollar | superseded | [clm_296E3EA8102E](/claim/clm_296E3EA8102E.md)

## 2024

- 2024-02-16 to 2024-04-25 | money | shares_outstanding | 950,164,452 shares | superseded | [clm_C1C0A1DB1A21](/claim/clm_C1C0A1DB1A21.md)
- 2024-03-31 to 2024-06-30 | money | cash_and_equivalents | 2,460,200,000 United States dollar | superseded | [clm_20E22D66C75D](/claim/clm_20E22D66C75D.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_net_income | 2,242,900,000 United States dollar | superseded | [clm_6D2F6DF42AAE](/claim/clm_6D2F6DF42AAE.md)
- 2024-03-31 to 2024-06-30 | money | quarterly_revenue | 8,768,000,000 United States dollar | superseded | [clm_1AD340C3A5DB](/claim/clm_1AD340C3A5DB.md)
- 2024-03-31 to 2024-06-30 | money | total_assets | 63,943,500,000 United States dollar | superseded | [clm_1552D301A5B6](/claim/clm_1552D301A5B6.md)
- 2024-03-31 to 2024-06-30 | money | total_equity | 12,812,200,000 United States dollar | superseded | [clm_873AD40D49EA](/claim/clm_873AD40D49EA.md)
- 2024-04-25 to 2024-08-05 | money | shares_outstanding | 950,405,386 shares | superseded | [clm_A61E12A06FAE](/claim/clm_A61E12A06FAE.md)
- 2024-06-30 to 2024-09-30 | money | cash_and_equivalents | 3,223,600,000 United States dollar | superseded | [clm_EB5CDAC12500](/claim/clm_EB5CDAC12500.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_net_income | 2,967,000,000 United States dollar | superseded | [clm_50DC2A117A21](/claim/clm_50DC2A117A21.md)
- 2024-06-30 to 2024-09-30 | money | quarterly_revenue | 11,302,800,000 United States dollar | superseded | [clm_3E94821DE7E1](/claim/clm_3E94821DE7E1.md)
- 2024-06-30 to 2024-09-30 | money | total_assets | 71,874,800,000 United States dollar | superseded | [clm_CD03F28D337B](/claim/clm_CD03F28D337B.md)
- 2024-06-30 to 2024-09-30 | money | total_equity | 13,562,000,000 United States dollar | superseded | [clm_FE31C6766A8C](/claim/clm_FE31C6766A8C.md)
- 2024-08-05 to 2024-10-25 | money | shares_outstanding | 950,425,778 shares | superseded | [clm_0C99C1CF2AF4](/claim/clm_0C99C1CF2AF4.md)
- 2024-09-30 to 2024-12-31 | money | cash_and_equivalents | 3,369,000,000 United States dollar | superseded | [clm_F6EB021B631B](/claim/clm_F6EB021B631B.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_net_income | 970,300,000 United States dollar | superseded | [clm_49D1BFE1C6AA](/claim/clm_49D1BFE1C6AA.md)
- 2024-09-30 to 2025-03-31 | money | quarterly_revenue | 11,439,100,000 United States dollar | superseded | [clm_0D9BE0B6BA02](/claim/clm_0D9BE0B6BA02.md)
- 2024-09-30 to 2024-12-31 | money | total_assets | 75,606,900,000 United States dollar | superseded | [clm_52866FB31BA7](/claim/clm_52866FB31BA7.md)
- 2024-09-30 to 2024-12-31 | money | total_equity | 14,240,000,000 United States dollar | superseded | [clm_F543E95F6B84](/claim/clm_F543E95F6B84.md)
- 2024-10-25 to 2025-02-14 | money | shares_outstanding | 949,315,694 shares | superseded | [clm_2F9C4C1E5AC6](/claim/clm_2F9C4C1E5AC6.md)
- 2024-12-31 to 2025-03-31 | money | cash_and_equivalents | 3,268,400,000 United States dollar | superseded | [clm_DBC8478F7F2C](/claim/clm_DBC8478F7F2C.md)
- 2024-12-31 to 2025-12-31 | money | net_income | 10,590,000,000 United States dollar | superseded | [clm_2BC21A73296C](/claim/clm_2BC21A73296C.md)
- 2024-12-31 to 2025-12-31 | money | revenue | 45,042,700,000 United States dollar | superseded | [clm_282E1F71B318](/claim/clm_282E1F71B318.md)
- 2024-12-31 to 2025-03-31 | money | total_assets | 78,714,900,000 United States dollar | superseded | [clm_4B929E4D8044](/claim/clm_4B929E4D8044.md)
- 2024-12-31 to 2025-03-31 | money | total_equity | 14,192,100,000 United States dollar | superseded | [clm_3C3D7729DB02](/claim/clm_3C3D7729DB02.md)

## 2025

- 2025-02-14 to 2025-04-28 | money | shares_outstanding | 948,169,999 shares | superseded | [clm_85B1F2DD64D4](/claim/clm_85B1F2DD64D4.md)
- 2025-03-31 to 2025-06-30 | money | cash_and_equivalents | 3,093,300,000 United States dollar | superseded | [clm_F076409F4247](/claim/clm_F076409F4247.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_net_income | 2,759,300,000 United States dollar | superseded | [clm_ABF5DA9F3F8E](/claim/clm_ABF5DA9F3F8E.md)
- 2025-03-31 to 2025-06-30 | money | quarterly_revenue | 12,728,500,000 United States dollar | superseded | [clm_684F3B3B6CFA](/claim/clm_684F3B3B6CFA.md)
- 2025-03-31 to 2025-06-30 | money | total_assets | 89,388,800,000 United States dollar | superseded | [clm_FFD575F8F24D](/claim/clm_FFD575F8F24D.md)
- 2025-03-31 to 2025-06-30 | money | total_equity | 15,764,800,000 United States dollar | superseded | [clm_BAC94969E9C8](/claim/clm_BAC94969E9C8.md)
- 2025-04-28 to 2025-08-04 | money | shares_outstanding | 947,735,651 shares | superseded | [clm_AA7B6785A235](/claim/clm_AA7B6785A235.md)
- 2025-06-30 to 2025-09-30 | money | cash_and_equivalents | 3,375,900,000 United States dollar | superseded | [clm_6393A6D7AE8B](/claim/clm_6393A6D7AE8B.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_net_income | 5,660,500,000 United States dollar | superseded | [clm_1D33827F581C](/claim/clm_1D33827F581C.md)
- 2025-06-30 to 2025-09-30 | money | quarterly_revenue | 15,557,700,000 United States dollar | superseded | [clm_7CBD9D7BE5AE](/claim/clm_7CBD9D7BE5AE.md)
- 2025-06-30 to 2025-09-30 | money | total_assets | 100,922,600,000 United States dollar | superseded | [clm_448FFB239F79](/claim/clm_448FFB239F79.md)
- 2025-06-30 to 2025-09-30 | money | total_equity | 18,272,900,000 United States dollar | superseded | [clm_8BC2286999EC](/claim/clm_8BC2286999EC.md)
- 2025-08-04 to 2025-10-27 | money | shares_outstanding | 946,456,759 shares | superseded | [clm_038B0512B15D](/claim/clm_038B0512B15D.md)
- 2025-09-30 to 2025-12-31 | money | cash_and_equivalents | 9,791,900,000 United States dollar | superseded | [clm_599C7D287C29](/claim/clm_599C7D287C29.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_net_income | 5,582,500,000 United States dollar | superseded | [clm_74B5C29B477B](/claim/clm_74B5C29B477B.md)
- 2025-09-30 to 2026-03-31 | money | quarterly_revenue | 17,600,800,000 United States dollar | superseded | [clm_D3881089FBD6](/claim/clm_D3881089FBD6.md)
- 2025-09-30 to 2025-12-31 | money | total_assets | 114,935,400,000 United States dollar | superseded | [clm_C3E87E59336F](/claim/clm_C3E87E59336F.md)
- 2025-09-30 to 2025-12-31 | money | total_equity | 23,793,300,000 United States dollar | superseded | [clm_AA3E6D040F0E](/claim/clm_AA3E6D040F0E.md)
- 2025-10-27 to 2026-02-09 | money | shares_outstanding | 945,383,757 shares | superseded | [clm_3242C5557E98](/claim/clm_3242C5557E98.md)
- 2025-12-31 to 2026-03-31 | money | cash_and_equivalents | 7,268,000,000 United States dollar | superseded | [clm_AEB07A485FC9](/claim/clm_AEB07A485FC9.md)
- 2025-12-31 | money | net_income | 20,640,000,000 United States dollar | valid | [clm_DBEC55E24C06](/claim/clm_DBEC55E24C06.md)
- 2025-12-31 | money | revenue | 65,179,000,000 United States dollar | valid | [clm_C4636B99C62B](/claim/clm_C4636B99C62B.md)
- 2025-12-31 to 2026-03-31 | money | total_assets | 112,476,000,000 United States dollar | superseded | [clm_C278ED944402](/claim/clm_C278ED944402.md)
- 2025-12-31 to 2026-03-31 | money | total_equity | 26,535,000,000 United States dollar | superseded | [clm_6628DA8282A8](/claim/clm_6628DA8282A8.md)

## 2026

- 2026-02-09 to 2026-04-27 | money | shares_outstanding | 943,357,420 shares | superseded | [clm_5A4FA78D8054](/claim/clm_5A4FA78D8054.md)
- 2026-03-31 to 2026-06-30 | money | cash_and_equivalents | 5,282,000,000 United States dollar | superseded | [clm_413E49925EF9](/claim/clm_413E49925EF9.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_net_income | 7,396,000,000 United States dollar | superseded | [clm_063460475B4C](/claim/clm_063460475B4C.md)
- 2026-03-31 to 2026-06-30 | money | quarterly_revenue | 19,799,000,000 United States dollar | superseded | [clm_DF742A5515B7](/claim/clm_DF742A5515B7.md)
- 2026-03-31 to 2026-06-30 | money | total_assets | 116,576,000,000 United States dollar | superseded | [clm_A36CAC6CDD99](/claim/clm_A36CAC6CDD99.md)
- 2026-03-31 to 2026-06-30 | money | total_equity | 31,198,000,000 United States dollar | superseded | [clm_288F177A8B4B](/claim/clm_288F177A8B4B.md)
- 2026-04-27 to 2026-08-03 | money | shares_outstanding | 941,741,406 shares | superseded | [clm_1DF27D28FE37](/claim/clm_1DF27D28FE37.md)
- 2026-06-30 to 2026-09-30 | money | cash_and_equivalents | 8,950,000,000 United States dollar | superseded | [clm_B021E511C567](/claim/clm_B021E511C567.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_net_income | 7,095,000,000 United States dollar | superseded | [clm_2FBA71C4F385](/claim/clm_2FBA71C4F385.md)
- 2026-06-30 to 2026-09-30 | money | quarterly_revenue | 22,974,000,000 United States dollar | superseded | [clm_D2C1E8A7329C](/claim/clm_D2C1E8A7329C.md)
- 2026-06-30 to 2026-09-30 | money | total_assets | 142,283,000,000 United States dollar | superseded | [clm_2F9AF66FD3E4](/claim/clm_2F9AF66FD3E4.md)
- 2026-06-30 to 2026-09-30 | money | total_equity | 33,879,000,000 United States dollar | superseded | [clm_B27C7F5364BF](/claim/clm_B27C7F5364BF.md)
- 2026-08-03 to 2026-10-26 | money | shares_outstanding | 941,357,065 shares | superseded | [clm_0BBEC8AC9C68](/claim/clm_0BBEC8AC9C68.md)
- 2026-09-30 | money | cash_and_equivalents | 4,885,000,000 United States dollar | valid | [clm_BC1171A7B218](/claim/clm_BC1171A7B218.md)
- 2026-09-30 | money | quarterly_net_income | 6,451,000,000 United States dollar | valid | [clm_9D57FD94603E](/claim/clm_9D57FD94603E.md)
- 2026-09-30 | money | quarterly_revenue | 24,397,000,000 United States dollar | valid | [clm_E1B01E0405B5](/claim/clm_E1B01E0405B5.md)
- 2026-09-30 | money | total_assets | 148,072,000,000 United States dollar | valid | [clm_D20ADDDE60AB](/claim/clm_D20ADDDE60AB.md)
- 2026-09-30 | money | total_equity | 40,271,000,000 United States dollar | valid | [clm_82ACC132512E](/claim/clm_82ACC132512E.md)
- 2026-10-26 | money | shares_outstanding | 940,745,031 shares | valid | [clm_ACF69B8AA825](/claim/clm_ACF69B8AA825.md)

## undated

- undated | other | cik | 0000059478 | valid | [clm_91F284A9D7C8](/claim/clm_91F284A9D7C8.md)
- undated | other | fiscal_year_end | 12-31 | valid | [clm_4809DE70CF2A](/claim/clm_4809DE70CF2A.md)
- undated | other | headquarters | Indianapolis | valid | [clm_8346D7F2C725](/claim/clm_8346D7F2C725.md)
- undated | other | listed_on | NYSE | valid | [clm_B1897509C990](/claim/clm_B1897509C990.md)
- undated | other | sic_industry | Pharmaceutical Preparations (2834) | valid | [clm_2509C2A3A267](/claim/clm_2509C2A3A267.md)
- undated | other | state_of_incorporation | IN | valid | [clm_A5EA16045303](/claim/clm_A5EA16045303.md)
- undated | other | ticker | LLY | valid | [clm_E590A7180C31](/claim/clm_E590A7180C31.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.